Navigation Links
Arthritis drugs safer than previously declared

A recently done review of findings published earlier, proves that the previous report exaggerated the risk that two drugs// show in raising the risk of cancer in those who use them.

Research done by Dr. Eric Matteson and colleagues at the Mayo Clinic in Rochester, New York in May 2006, dealing with the study of two drugs 'Humira' and 'Remicade' used currently by physicians to treat rheumatoid arthritis surfaced with findings that pointed out a heavy probability of development of cancer and infections like tuberculosis, in those who use them regularly.This information was was exhibited on labels according to the order of the FDA six months earlier.

However several teams of researchers have since then studied the same drugs all over again in a review to re affirm if they actually triple the chances of cancerous lesions and infections. Their review has projected new data which hints that risk of cancer is not as high as that was proclaimed in the previous studies. The Journal of the American Medical Association has published a number of letters from researchers who have reviewed the drugs again which claims that the use of drug Humira and Remicade only doubles the chances of carcinoma and may work against other auto immune diseases such as skin conditions such as psoriasis, ulcerative colitis.

Almost all the researchers, and the U.S. FDA feel in unison that it is the right of every to know about the risks but also opine that the benefits reflect that the drugs should stay on the market.

Matteson and his colleagues re did the analysis done in May and after considering certain data which were not analysed earlier reached the conclusion that the drugs may not triple the chances of cancer but only double the chances as these two drugs act on the auto immune system blocking the action of TNF-alpha one of the target compounds which mistakenly signals to the immune system to attack the joints as in rheumatoid arthritis.It is now an established fact that any drug that is capable of modifying the immune system can also cause cancer.

Another drug of the same class Enbrel is also being studied by researchers to look into possibilities of causing cancer or infections.

The market for drugs to treat Rheumatoid arthritis is on an upswing following the increase in number of Americans that are affected by rheumatoid arthritis according to the findings noted by market research company Research and Markets.
MST
'"/>




Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Naked DNA Vaccination May Conquer Arthritis and Multiple Sclerosis
3. B Vitamin protects and lowers toxicity of Arthritis Drug
4. FDA Approves New Arthritis Drug, Bextra
5. Risk Of Developing Arthritis
6. Arthritis Drug May Cause Liver Damage
7. Arthritis drug can prolong life
8. New treatment for Rheumatoid Arthritis
9. Important cause of Arthritis
10. Personality Impacts Arthritis
11. New Rheumatoid Arthritis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
(Date:6/23/2016)... , June 23, 2016 The vast ... an outpatient dialysis facility.  Treatments are usually 3 times ... hours per visit, including travel time, equipment preparation and ... patient, but especially grueling for patients who are elderly ... a skilled nursing and rehabilitation centers for some duration ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
Breaking Medicine Technology: